Get the Stockscreener App
1.70
0.59%
0.01
After Hours:
1.68
-0.02
-1.18%
Pulmonx Corp stock is traded at $1.70, with a volume of 248.14K.
It is up +0.59% in the last 24 hours and up +6.92% over the past month.
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
See More
Previous Close:
$1.69
Open:
$1.7
24h Volume:
248.14K
Relative Volume:
0.42
Market Cap:
$69.27M
Revenue:
$68.68M
Net Income/Loss:
$-60.84M
P/E Ratio:
-1.0625
EPS:
-1.6
Net Cash Flow:
$-38.42M
1W Performance:
-2.30%
1M Performance:
+6.92%
6M Performance:
-76.78%
1Y Performance:
-79.22%
1-Day Range:
$1.67
$1.76
1-Week Range:
$1.60
$1.775
52-Week Range:
$1.47
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
Name
Pulmonx Corp
Sector
Industry
Phone
650-364-0400
Address
700 CHESAPEAKE DRIVE, REDWOOD CITY
Compare LUNG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.70 | 65.60M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-10-25 | Initiated | D. Boral Capital | Buy |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-04-24 | Initiated | Lake Street | Buy |
| Feb-23-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Sep-05-23 | Initiated | Craig Hallum | Buy |
| Feb-27-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Mar-25-21 | Initiated | Piper Sandler | Neutral |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-26-20 | Initiated | BofA Securities | Buy |
| Oct-26-20 | Initiated | Canaccord Genuity | Buy |
| Oct-26-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-26-20 | Initiated | Stifel | Buy |
| Oct-26-20 | Initiated | Wells Fargo | Equal Weight |
View All
Pulmonx Corp Stock (LUNG) Latest News
D. Boral Capital Reaffirms "Buy" Rating for Pulmonx (NASDAQ:LUNG) - MarketBeat
Will Pulmonx Corporation rebound enough to break evenJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - Newser
Can you recover from losses in Pulmonx CorporationGDP Growth & Fast Gain Stock Trading Tips - Newser
Is Pulmonx Corporation stock bottoming outJuly 2025 Breakouts & Smart Money Movement Tracker - Newser
Is it time to cut losses on Pulmonx CorporationLayoff News & Verified Short-Term Plans - Newser
Pattern recognition hints at Pulmonx Corporation upsideVolume Spike & Community Trade Idea Sharing - Newser
Is Pulmonx Corporation forming a reversal pattern2025 Big Picture & Real-Time Stock Entry Alerts - Newser
Intraday pattern recognizer results for Pulmonx CorporationJuly 2025 Price Swings & Weekly Breakout Stock Alerts - Newser
Parkman Healthcare Partners LLC Has $4.12 Million Stake in Pulmonx Corporation $LUNG - MarketBeat
visual trend scoring systems applied to pulmonx corporation2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
Can trapped investors hope for a rebound in Pulmonx Corporation2025 Biggest Moves & Long-Term Investment Growth Plans - Newser
Chart overlay techniques for tracking Pulmonx Corporation2025 Major Catalysts & Target Return Focused Picks - Newser
Signal strength of Pulmonx Corporation stock in tech scannersWeekly Market Report & Daily Technical Forecast Reports - Newser
Custom strategy builders for tracking Pulmonx CorporationTrade Performance Summary & Target Return Focused Stock Picks - Newser
What Fibonacci levels say about Pulmonx Corporation rebound2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - Newser
Is Pulmonx Corporation stock poised for growth2025 Technical Overview & Technical Buy Zone Confirmation - Newser
Insider Selling: Pulmonx (NASDAQ:LUNG) Insider Sells 6,543 Shares of Stock - MarketBeat
Using R and stats models for Pulmonx Corporation forecastingWeekly Profit Recap & Weekly Watchlist of Top Performers - Newser
Backtesting results for Pulmonx Corporation trading strategies2025 Price Action Summary & Momentum Based Trading Ideas - Newser
Using economic indicators to assess Pulmonx Corporation potentialPortfolio Growth Summary & Real-Time Market Trend Scan - Newser
Pulmonx Corporation Rebounds From Oversold Zone — Now What2025 Risk Factors & Free Risk Controlled Daily Trade Plans - beatles.ru
What to do if you’re stuck in Pulmonx CorporationQuarterly Risk Review & Long-Term Capital Growth Strategies - Newser
Pulmonx (NASDAQ:LUNG) General Counsel David Aaron Lehman Sells 9,769 Shares - MarketBeat
How to track smart money flows in Pulmonx Corporation2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - Newser
Real time pattern detection on Pulmonx Corporation stock2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser
Chart based analysis of Pulmonx Corporation trends2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
Nuveen LLC Takes Position in Pulmonx Corporation $LUNG - MarketBeat
Pulmonx at Wells Fargo Conference: Strategic Growth and Challenges By Investing.com - Investing.com South Africa
Pulmonx Corporation Reaches Critical Trendline SupportWeekly Risk Summary & Safe Swing Trade Setup Alerts - beatles.ru
Pulmonx at Wells Fargo Conference: Strategic Growth and Challenges - Investing.com
Will Pulmonx Corporation stock recover after recent dropJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser
Pulmonx (NASDAQ:LUNG) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Will Pulmonx Corporation bounce back from current supportJuly 2025 Rallies & Daily Chart Pattern Signals - Newser
Pulmonx Corp Executives Sell Shares to Cover Tax Obligations - TradingView
Will breakout in Pulmonx Corporation lead to full recoveryJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - Newser
How to build a custom watchlist for Pulmonx CorporationWeekly Profit Summary & Weekly High Potential Stock Alerts - Newser
Using data tools to time your Pulmonx Corporation exitJuly 2025 Institutional & Verified Short-Term Plans - Newser
What data driven models say about Pulmonx Corporation’s future2025 Geopolitical Influence & Reliable Volume Spike Alerts - Newser
What are the future prospects of Pulmonx CorporationMarket Volume Report & Long-Term Safe Investment Plans - khodrobank.com
Pulmonx Corp Stock (LUNG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):